Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

NCT01211834 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: tocilizumab
DRUG: DMARDs
DRUG: Placebo
DRUG: DMARDs

Sponsor

JW Pharmaceutical